Carmen Brace will jointly present the results of the latest Aclara Research study - Impact of Medical Cannabis on Prescription Drug and Opioid Usage- with Luba Andrus, RPh, VIce President of Patient Care, MedMar Dispensaries of Illinois, and Anne Berg, PharmD, at the American Society of Consultant Pharmacists (ASCP) Annual Meeting.
Carmen Brace joins Illinois medical professionals and dispensary owners to present the results of the Illinois Patient Experience study at the Lake County Canna Expo. Join us to learn more about your questions regarding medical cannabis.
Carmen joins a panel of colleagues in Michigan cannabis industry to discuss the experience of entrepreneurship as a consumer insights research professional, a woman and as a person of color.
A new research study conducted on patients enrolled in Illinois' pilot medical marijuana program has found that cannabis treatments have helped patients cut back on prescription drug use, or even quit entirely. Medical cannabis consulting firm Aclara Research recently released The Illinois Medical Cannabis Patient Experience Study, the first study on the effectiveness of the state's pilot MMJ program, which was launched in 2012.
A study of patients in Illinois suggests that CBD products are nearly as popular as THC products, and that women are the driving force behind sales of the former. The Illinois Medical Cannabis Patient Experience Study – conducted by Aclara Research, a Chicago medical marijuana patient research firm – found that 47% of patients said they use CBD daily and 22% had no previous experience with marijuana before joining the state’s MMJ program.
CHICAGO, May 23, 2017 (GLOBE NEWSWIRE) -- Aclara Research, a leader in the development of patient and consumer insights within the medical cannabis industry, today released the results of The Illinois Medical Cannabis Patient Experience Study - the first of Illinois patients since the inception of the pilot program in 2012. The study is the largest and most comprehensive look at the impact of the statewide program, examining nearly 300 of the 18,000 Illinois residents registered.